Comparison of oral-steroid sparing by high-dose and low-dose inhaled steroid in maintenance treatment of severe asthma

作者: S. Hummel , L. Lehtonen

DOI: 10.1016/0140-6736(92)92750-A

关键词:

摘要: Abstract It is not clear whether high doses of inhaled steroids have a greater sparing effect than low on the requirement for systemic steroids. In randomised, double-blind, multicentre study, we compared effects high-dose (1500 μg/day) and low-dose (300 beclomethasone diproprionate (BDP) in patients with severe asthma requiring daily oral prednisolone dose 10-40 mg. During 3-month run-in period, tried to achieve optimum control by means steroid BDP 300 μg/day. The were then allocated (n=71) or (n = 72) treatment an independent observer who took into account various prognostic factors. was administered aerosol inhaler spacer device. reduced as much possible during 6-month study period while keeping peak expiratory flow (PEF) constant clinically stable. There no difference between groups mean reduction achieved end (5·2 [SD 7·9] vs 5·0 [9·4] mg/day). maximum response seen, however, only after several months' therapy both groups. differences use on-demand β-agonist inhalations symptoms, PEF values throughout study. Both well tolerated. High offer further benefit over maintenance steroid-dependent when

参考文章(18)
Julian Crane, Neil Pearce, Richard Beasley, Carl Burgess, Worldwide worsening wheezing—is the cure the cause? The Lancet. ,vol. 339, pp. 814- ,(1992) , 10.1016/0140-6736(92)91946-6
Sergio Salmeron, Jean-Claude Guerin, Philippe Godard, Dominique Renon, Michel Henry-Amar, Pierre Duroux, André Taytard, High Doses of Inhaled Corticosteroids in Unstable Chronic Asthma: A Multicenter, Double-blind, Placebo-controlled Study The American review of respiratory disease. ,vol. 140, pp. 167- 171 ,(1989) , 10.1164/AJRCCM/140.1.167
Susan M. Tarlo, Irvin Broder, Geoffrey M. Davies, Arthur Leznoff, Sheldon Mintz, Paul N. Corey, Six-Month Double-Blind, Controlled Trial of High Dose, Concentrated Beclomethasone Dipropionate in the Treatment of Severe Chronic Asthma Chest. ,vol. 93, pp. 998- 1002 ,(1988) , 10.1378/CHEST.93.5.998
P DYER, T VAUGHAN, R WEBER, Methotrexate in the treatment of steroid-dependent asthma Journal of Allergy and Clinical Immunology. ,vol. 88, pp. 208- 212 ,(1991) , 10.1016/0091-6749(91)90330-Q
A.G. Alexander, A.B. Kay, N.C. Barnes, Trial of cyclosporin in corticosteroid-dependent chronic severe asthma The Lancet. ,vol. 339, pp. 324- 328 ,(1992) , 10.1016/0140-6736(92)91646-P
M.R. Sears, D.R. Taylor, C.G. Print, D.C. Lake, Q. Li, E.M. Flannery, D.M. Yates, M.K. Lucas, G.P. Herbison, Regular inhaled beta-agonist treatment in bronchial asthma The Lancet. ,vol. 336, pp. 1391- 1396 ,(1990) , 10.1016/0140-6736(90)93098-A
Stuart J. Pocock, Richard Simon, Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial Biometrics. ,vol. 31, pp. 103- 115 ,(1975) , 10.2307/2529712
R.J. Shiner, A.J. Nunn, K.F. Chung, D.M. Geddes, Randomised, double-blind, placebo-controlled trial of methotrexate in steroid-dependent asthma The Lancet. ,vol. 336, pp. 137- 140 ,(1990) , 10.1016/0140-6736(90)91659-X
J TOOGOOD, N LEFCOE, D HAINES, B JENNINGS, N ERRINGTON, L BAKSH, L CHUANG, A graded dose assessment of the efficacy of beclomethasone dipropionate aerosol for severe chronic asthma The Journal of Allergy and Clinical Immunology. ,vol. 59, pp. 298- 308 ,(1977) , 10.1016/0091-6749(77)90051-3